{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.03, "epsForward": 0.02, "sharesOutstanding": 119924000, "bookValue": 0.015, "fiftyDayAverage": 0.02946, "fiftyDayAverageChange": 0.00053999946, "fiftyDayAverageChangePercent": 0.01832992, "twoHundredDayAverage": 0.04154608, "twoHundredDayAverageChange": -0.011546081, "twoHundredDayAverageChangePercent": -0.27791023, "marketCap": 3597720, "forwardPE": 1.5, "priceToBook": 2.0, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "prevName": "Anatara Lifesciences Limited", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "currency": "AUD", "financialCurrency": "AUD", "regularMarketOpen": 0.03, "averageDailyVolume3Month": 73065, "averageDailyVolume10Day": 126599, "fiftyTwoWeekLowChange": 0.003999999, "fiftyTwoWeekLowChangePercent": 0.1538461, "fiftyTwoWeekRange": "0.026 - 0.092", "fiftyTwoWeekHighChange": -0.062, "fiftyTwoWeekHighChangePercent": -0.673913, "fiftyTwoWeekLow": 0.026, "fiftyTwoWeekHigh": 0.092, "earningsTimestamp": 1677236340, "earningsTimestampStart": 1677236340, "earningsTimestampEnd": 1677236340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1413414000000, "priceHint": 4, "marketState": "PRE", "regularMarketChange": 0.0, "regularMarketTime": 1683775131, "regularMarketDayHigh": 0.03, "regularMarketDayRange": "0.028 - 0.03", "regularMarketDayLow": 0.028, "regularMarketVolume": 703450, "regularMarketPreviousClose": 0.03, "bid": 0.027, "ask": 0.03, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.03, "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "esgPopulated": false, "exchange": "ASX", "shortName": "ANATARA LS FPO", "longName": "Anatara Lifesciences Ltd", "messageBoardId": "finmb_271680201", "market": "au_market", "symbol": "ANR.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "81 Flinders Street", "address2": "Level 8", "city": "Adelaide", "state": "SA", "zip": "5000", "country": "Australia", "phone": "61 3 9824 5454", "fax": "61 4 3802 7172", "website": "https://anataralifesciences.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Adelaide, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. David Lionel Brookes FACRRM, FAICD, MBBS", "age": 62, "title": "Exec. Chairman", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 118821, "fmt": "118.82k", "longFmt": "118,821"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Michailidis B.Sc., EMBA, M.A.I.C.D.", "title": "Chief Operations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jane  Lowe", "title": "Managing Director of IR Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  Erskine", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephen  Denaro AGIA, BCom, CA, GradDipApp CG, MAICD", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Hayley  van der Meer B Biomed Sc, Grad Dip Marketing Management", "title": "Commercial Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}